XJPX
4369
Market cap700mUSD
Oct 09, Last price
3,475.00JPY
1D
2.06%
1Q
4.51%
Jan 2017
495.80%
IPO
1,914.49%
Name
Tri Chemical Laboratories Inc
Chart & performance
P/E
20.48
P/S
4.73
EPS
169.72
Div yield, %
1.03%
Shrs. gr., 5y
0.79%
Rev. gr., 5y
19.50%
Revenues
23.88b
+26.33%
Net income
5.52b
+11.15%
CFO
3.80b
+3.27%
Dividend
Jan 28, 202735 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 1978 and headquartered in Uenohara, Japan, Tri Chemical Laboratories Inc. develops and supplies essential chemical compounds for cutting-edge industries. The company provides crucial precursors for the production of semiconductors, optical fibers, solar cells, and compound semiconductors. Additionally, its chemical offerings include catalysts and various specialized reagents. Beyond chemicals, Tri Chemical Laboratories Inc. also manufactures a comprehensive selection of containment products, such as stainless-steel vessels equipped with valves, seamless cylinders for high-pressure gas applications, glass ampoules, and a range of bottles made from polyethylene or glass.
Key people
Tadaaki Hiraki
Executive Officer · since 2024
Satoru Mihashi
Executive Officer · since 2024
Tatsuya Ohira
Executive Officer · since 2022
Hironobu Ohsugi
Executive Officer, Director · since 2023
Masahito Shibata
Executive Officer, Chairman of Subsidiary · since 2022
Yoshihide Suzuki
Executive Officer, Director · since 2024
Akira Tabaru
Executive Officer · since 2024
Takashi Udagawa
Executive Officer · since 2022
Jumpei Takenaka
Chairman of the Board, Representative Director · since 2016
Kiyoshi Tazuke
Executive President, Chief Executive Officer, Representative Director · since 2022
Toshihisa Hashimoto
Independent Director · since 2023
Hitoshi Iida
Independent Director · since 2024
Kyoko Kato
Independent Director · since 2024
Headquarters & legal address
上野原8154番地217
山梨県 上野原市 409-0112
JP
山梨県 上野原市 409-0112
JP
Address
8154-217,Uenohara
Uenohara-shi Yamanashi 409-0112
JP
Uenohara-shi Yamanashi 409-0112
JP
Other language
Tri Chemical Laboratories Inc.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑01 | 2025‑01 | 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | 2017‑01 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||